Regulation of Renal Hemodyamics by Purinergic Receptors in Angiotensin II -Induced Hypertension

QR Code

Regulation of Renal Hemodyamics by Purinergic Receptors in Angiotensin II -Induced Hypertension

None

Saved in:

Bibliographic Details
Main Authors:	Franco, Martha, Bautista-Pérez, Rocío, Pérez-Méndez, Oscar
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/36120
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Radioligands Targeting the Purinergic P2X Receptors
by: Diego Dal Ben, et al.
Published: (2025-06-01)

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS
by: D. V. Nebieridze
Published: (2002-02-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

PURINERGIC REGULATION OF BASIC PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES
by: A. S. Golovkin, et al.
Published: (2018-06-01)

Facilitation of Neurotransmitter and Hormone Release by P2X Purinergic Receptors
by: Vavra, Vojtech, et al.
Published: (2012)

Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists
by: E. O. Taratukhin
Published: (2012-12-01)

Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors
by: R. D. Smith, et al.
Published: (2010-12-01)

Metabolic syndrome and angiotensin II receptor antagonists
by: K. M. Mamyrbayeva, et al.
Published: (2007-04-01)

Angiotensin II receptor inhibitors: role and place in arterial hypertension and metabolic syndrome treatment
by: I. N. Medvedev, et al.
Published: (2007-10-01)

The Involvement of Purinergic System in Pain: Adenosine Receptors and Inosine as Pharmacological Tools in Future Treatments
by: Nascimento, Francisney Pinto, et al.
Published: (2012)

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.
by: Mingfei Li, et al.
Published: (2021-01-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
by: V. V. Fomin
Published: (2013-08-01)

Anti-inflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation
by: Danilo Fliser, et al.
Published: (1970-01-01)

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
by: V. V. Fomin, et al.
Published: (2007-06-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Anti-remodeling efficacy of eprosartan in patients with essential hypertension, and gene polymorphism of angiotensin II type 1 receptors
by: B. Sh. Karimova, et al.
Published: (2005-02-01)

Angiotensin II receptor antagonists – we have moved closer to the patient
by: L. G. Ratova, et al.
Published: (2005-04-01)

ANGIOTENSIN II RECEPTOR TYPE 1 EXPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
by: I. S. Mykhailichenko
Published: (2016-04-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-06-01)

Ultrastructural changes of platelet granules in patients with type 2 diabetes mellitus and hypertension in applying of angiotensin II receptor antagonists
by: Pertseva N.O.
Published: (2016-06-01)

Ultrastructural changes of platelet granules in patients with type 2 diabetes mellitus and hypertension in applying of angiotensin II receptor antagonists.
by: N. O. Pertseva
Published: (2016-06-01)

Effect of insertion/deletion polymorphism of angiotensin-converting enzyme gene on efficacy of antihypertensive therapy with angiotensin II receptor blockers
by: E. V. Rebrova, et al.
Published: (2024-01-01)

Expression of angiotensin II type 2 receptors and syndecan-1 in prostate cancer
by: E. A. Chernogubova, et al.
Published: (2024-11-01)

Clinical pharmacogenetics of angiotensin II receptor blockers: new perspectives of pharmacotherapy individualization
by: D. A. Sychev, et al.
Published: (2006-04-01)

INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS
by: V. V. Fomin
Published: (2016-01-01)

Gene polymorphism of endothelial NO-synthase, angiotensin-converting enzyme and receptors of angiotensin II type 1 in patients with coronary artery disease and type II diabetes.
by: L. M. Yakovleva
Published: (2013-12-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Angiotensin receptor-1 antagonist eprosartan in patients with mild to moderate arterial hypertension
by: A. V. Shabalin, et al.
Published: (2005-12-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS
by: V. S. Zadionchenko, et al.
Published: (2015-12-01)

EFFICACY AND SAFE USE OF SPECIFIC ANGIOTENSIN II RECEPTOR ANTAGONIST IRBESARTAN FOR CURING ARTERIAL HYPERTENSION IN CHILDREN AND TEENAGERS: A CLINICAL STUDY
by: L.P. Zharkova, et al.
Published: (2007-05-01)

ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES
by: E. O. Taratukhin
Published: (2013-06-01)

Difficult choice: angiotensin receptor antagonists
by: E. O. Taratukhin
Published: (2013-04-01)

Angiotensin Receptor Blockade Does Not Decrease Synthetic Angiotensin II (Giapreza<sup>®</sup>) Effectiveness in Perioperative Hypotension Surrounding Kidney Transplant
by: Natalie Pettit, et al.
Published: (2025-06-01)

ANGIOTENSIN II AND MYOCARDIAL INFARCTION
by: O. P. Shevchenko, et al.
Published: (2016-01-01)

Effect of angiotensin II receptor blocker therapy on markers of fibrosis and immune inflammation in hypertensive patients with chronic kidney disease after ischemic stroke
by: O. A. Osipova, et al.
Published: (2021-11-01)

Association of angiotensinogen and angiotensin II receptor type I polymorphisms with biomarkers of carbohydrate and lipid metabolism in Dagestan residents with type 2 diabetes and hypertension
by: M. Z. Saidov, et al.
Published: (2021-11-01)

EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY
by: S. N. Tolpygina, et al.
Published: (2016-01-01)